๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP ยท Real-Time Price ยท USD
10.52
-0.74 (-6.57%)
Nov 20, 2026, 4:00 PM EST - Market closed

ArriVent BioPharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-181-177.53-94.31-74.59-36.91-11.59
Net Income
-169.97-166.31-80.49-69.33-36.91-68.81
Earnings Per Share
-3.67-4.32-2.56-32.38-28.90-96.75
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
393.22312.82218.86150.39163.3737.28
Total Debt
0.260.010.180.320.14-
Net Cash (Debt)
392.97312.81218.69150.07163.2337.28
Net Cash Growth
30.90%43.04%45.72%-8.06%337.86%-
Net Cash Per Share
8.498.136.9570.10127.8252.42

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-152.84-160.59-70.21-55.84-43.63-16.78
Free Cash Flow
-152.84-160.59-70.21-55.84-43.63-16.78
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.